The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 26042340 |
77 |
Development of novel CXC chemokine receptor 7 (CXCR7) ligands: selectivity switch from CXCR4 antagonists with a cyclic pentapeptide scaffold. |
Kyoto University |
| 23656360 |
23 |
Optimized method of G-protein-coupled receptor homology modeling: its application to the discovery of novel CXCR7 ligands. |
Pharmadesign |
| 22424612 |
29 |
Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists. |
Vu University Amsterdam |
| 32551020 |
15 |
Discovery of Diphenylacetamides as CXCR7 Inhibitors with Novel ?-Arrestin Antagonist Activity. |
Pfizer |
| 31298539 |
18 |
Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68). |
Icahn School of Medicine At Mount Sinai |
| 30015488 |
44 |
Discovery, Synthesis, Pharmacological Profiling, and Biological Characterization of Brintonamides A-E, Novel Dual Protease and GPCR Modulators from a Marine Cyanobacterium. |
University of Florida |
| 29627981 |
45 |
Discovery of a Novel Small-Molecule Modulator of C-X-C Chemokine Receptor Type 7 as a Treatment for Cardiac Fibrosis. |
Pfizer |
| 29608300 |
118 |
Structure-Activity Relationship Study of Cyclic Pentapeptide Ligands for Atypical Chemokine Receptor 3 (ACKR3). |
Kyoto University |
| 29406702 |
128 |
Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists. |
Gsk Pharmaceuticals R & D |
| 29045152 |
55 |
Discovery of Potent and Orally Bioavailable Macrocyclic Peptide-Peptoid Hybrid CXCR7 Modulators. |
Pfizer |
| 6123593 |
24 |
A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain. |
Eli Lilly |
Search and Browse
